CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,906 | -84.7% | 82,087 | -74.3% | 0.00% | – |
| Q2 2023 | $902,728 | -67.2% | 318,985 | -43.1% | 0.00% | -100.0% |
| Q1 2023 | $2,752,404 | +54.5% | 560,571 | +237.9% | 0.00% | – |
| Q4 2022 | $1,781,573 | +19.8% | 165,882 | +4.4% | 0.00% | – |
| Q3 2022 | $1,487,000 | -47.7% | 158,869 | -49.0% | 0.00% | -100.0% |
| Q2 2022 | $2,842,000 | -19.1% | 311,230 | +7.7% | 0.00% | 0.0% |
| Q1 2022 | $3,512,000 | +67.4% | 289,073 | +67.8% | 0.00% | – |
| Q4 2021 | $2,098,000 | -42.0% | 172,227 | -26.4% | 0.00% | – |
| Q3 2021 | $3,616,000 | +56.7% | 234,076 | +44.7% | 0.00% | – |
| Q2 2021 | $2,308,000 | -79.8% | 161,729 | -69.3% | 0.00% | -100.0% |
| Q1 2021 | $11,448,000 | +101.6% | 527,342 | +40.5% | 0.00% | +50.0% |
| Q4 2020 | $5,678,000 | +106.3% | 375,314 | +73.6% | 0.00% | – |
| Q3 2020 | $2,752,000 | +41.1% | 216,188 | +89.6% | 0.00% | – |
| Q2 2020 | $1,950,000 | +62.6% | 114,016 | +25.6% | 0.00% | – |
| Q1 2020 | $1,199,000 | -54.1% | 90,800 | -44.0% | 0.00% | -100.0% |
| Q4 2019 | $2,614,000 | -74.7% | 162,269 | -71.3% | 0.00% | -83.3% |
| Q3 2019 | $10,334,000 | +0.5% | 565,336 | +18.2% | 0.01% | +20.0% |
| Q2 2019 | $10,285,000 | +31.2% | 478,338 | +19.7% | 0.01% | +25.0% |
| Q1 2019 | $7,842,000 | +271.1% | 399,742 | +146.0% | 0.00% | +300.0% |
| Q4 2018 | $2,113,000 | -47.2% | 162,505 | -2.8% | 0.00% | -50.0% |
| Q3 2018 | $4,004,000 | +22.8% | 167,211 | -1.8% | 0.00% | 0.0% |
| Q2 2018 | $3,260,000 | +143.6% | 170,271 | +57.6% | 0.00% | +100.0% |
| Q1 2018 | $1,338,000 | -8.5% | 108,071 | -9.6% | 0.00% | 0.0% |
| Q4 2017 | $1,463,000 | -27.8% | 119,571 | -19.2% | 0.00% | -50.0% |
| Q3 2017 | $2,027,000 | -21.9% | 148,071 | -12.2% | 0.00% | -33.3% |
| Q2 2017 | $2,595,000 | -25.5% | 168,637 | -10.9% | 0.00% | 0.0% |
| Q1 2017 | $3,482,000 | +869.9% | 189,353 | +390.0% | 0.00% | – |
| Q4 2016 | $359,000 | -36.3% | 38,647 | -42.7% | 0.00% | – |
| Q3 2016 | $564,000 | -63.6% | 67,465 | -26.7% | 0.00% | -100.0% |
| Q4 2015 | $1,551,000 | +78.9% | 92,021 | +51.7% | 0.00% | +100.0% |
| Q3 2015 | $867,000 | – | 60,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |